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The livers of gsd/gsd rats homozygous for the glycogen storage disease phosphorylase b kinase deficiency 
were observed by 13C NMR using a surface coil. Clear signals were detected from glycogen. The 
concentration of glycogen as determined by NMR was -3-times that found in normal strains agreeing well 
with chemical determinations. Starvation did not significantly reduce the glycogen content of the livers 
with glycogen storage disease whereas it reduced the signal below detectability in normal rats. Difference 
spectra of starved normal rats from fed gsd/gsd rats gave spectra similar in appearance to that of purified 
glycogen. Glycogen both in vivo and in vitro is fully visible using r3C NMR. 
Surface coil 13C natural abundance Phosphorylase kinase deficiency gsd/gsd rat Liver 
1. INTRODUCTION 
Nuclear magnetic resonance studies have yielded 
much information on the metabolism and localisa- 
tion of compounds in situ in living animals [ 11, but 
few such studies have been performed by r3C 
NMR. In [2] surface coils were used to obtain spec- 
tra from the naturally abundant (- 1% of total car- 
bon) 13C in rat organs and human arms in vivo. 
They were able to obtain a resonance correspon- 
ding to liver glycogen after enriching the 13C con- 
tent of the glycogen by feeding [l-13C]-glucose. No 
signals were observed from the native glycogen in 
these experiments, however. 
normal and gsd/gsd rats, and they corresponded in 
amount to the total glycogen assayed by orthodox 
methods. 
2. MATERIALS AND METHODS 
2.1. Animals 
A strain of rats (gsd/gsd) has been described in 
which liver phosphorylase kinase is absent so that 
phosphorylase a cannot be formed [3,4]. They 
have -3-fold higher glycogen levels in their livers 
than do normal, well-fed rats. Here, we report high 
resolution natural abundance 13C spectra of nor- 
mal and gsd/gsd rat liver in situ, obtained, using 
surface coils, at a frequency of 50.24 MHz. Clear 
signals from glycogen were obtained both from 
Rats (200-250 g) homozygous for phosphorylase 
b kinase deficiency (gsd/gsd) were obtained from 
the Department of Clinical Biochemistry, Medical 
School, University of Otago (Dunedin) and bred in 
the Animal House at St George’s Hospital Medical 
School (London). The primary defect in these 
animals is a deficiency in hepatic phosphorylase b 
kinase [3,4]. Porton Wistar rats bred in the Animal 
House at the National Institute for Medical Re- 
search (London) were used as controls. All rats 
were maintained on Oxoid 41B animal diet for at 
least 2 weeks before use. 
2.2. NA4R spectra 
Male gsd/gsd or Wistar rats were anaesthetised 
by intraperitoneal sodium pentobarbital injection, 
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and secured vertically within a purpose-built, 7 cm 
diam. NMR probe. By means of an abdominal in- 
cision a flat one turn 30 mm diam. radiofrequency 
(rf) coil was placed on the surface of the liver and 
within this was placed a two-turn rf coil of 20 mm 
diam. The larger coil was tuned to 200 MHz and 
used to decouple the protons, while the smaller coil 
was used for detection of the 13C signal. To prevent 
evaporation and to electrically insulate the coil, the 
liver surface was covered with a thin plastic film. 
The probe was inserted into the magnet of a wide 
bore Bruker WM200 spectrometer. r3C spectra 
were recorded at an irradiation frequency of 
50.24 MHz and a sweep width of + 7000 Hz. 
Radiofrequency pulses of 20.0 ps pulse width with 
a recycle time of 1 s were used (longer delay times 
did not significantly alter the observed signal inten- 
sities). Broad band decoupling (3 W effective) was 
used during data acquisition; it was reduced to a 
lower level during the remainder of the cycle in 
order to prevent overheating of the sample while 
maintaining Nuclear Overhauser Enhancement 
(NOE). The decoupler irradiation was centered on 
the CH2 proton frequency. For all spectra the line 
broadening was 12 Hz. 
2.3. Glycogen determination 
Tissue samples for glycogen assay were weighed 
in tubes containing 200~1 30% (w/v) KOH 
saturated with Na2SOd. They were digested in a 
boiling water bath for 60 min and the glycogen was 
a 
;.-,I 
I 
isolated by precipitation with ethanol. The 
glycogen was redissolved in 1 ml H20 and assayed 
by an enzymatic method in which glycogen was 
digested with amyloglucosidase as in [5] and the 
resulting glucose solution assayed as in [6]. 
3. RESULTS AND DISCUSSION 
Natural abundance 13C spectra of (a) normal 
liver and (b) gsd/gsd liver in vivo are shown in 
fig. 1. The Nuclear Overhauser Effect induced by 
proton decoupling leads to a 3-fold improvement 
in signal/noise and results in acceptable spectra be- 
ing obtained over 40 min (2500 scans). Chemical 
shifts are recorded relative to tetramethylsilane 
(TMS). The chemical shifts of substances in solu- 
tion were measured relative to a capillary of dioxan 
as a secondary standard. 
3.1. Assignment of resonances 
Major 13C resonances have been identified in 
whole tissue and extracts [2,7,8]. The aliphatic 
region of the liver spectrum (O-100 ppm) contains 
a major peak at 30.0 ppm (I in fig. 1) which is 
almost entirely due to the (CH& repeating unit of 
fatty acid chains situated in triglycerides and 
phospholipids [9,10]. The shoulders on this 
resonance are thought to be due to the y and 6 car- 
bons of several amino acids and the ,0 carbons of 
amino acid side chains of proteins capable of free 
motion [l 11. Resonance (H) in fig. 1 at 54.8 ppm 
b 
, 
Fig. 1. Proton decoupled SO.24 MHz 13C NMR spectra (2500 scans) of livers from fed rats (a) in vivo normal (b) phos- 
phorylase kinase-deficient (gsd/gsd). Pulses were applied every 1 s. Peak assignments are given in the text. Line 
broadening of 12 Hz was applied. Chemical shifts are given relative to TMS. 
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has been identified as the methyl group of choline 
by measuring the r3C spectrum of a piece of excised 
liver bathed in a solution of choline. The spectrum 
(not shown) was similar to that of liver in vivo ex- 
cept that resonance H was much larger. Peaks 
E-G, only clearly visible in the spectrum of the 
gsd/gsd liver (fig. lb) and peak D, have been 
assigned to glycogen from comparison with a spec- 
trum of pure glycogen (fig. 3b). Peak D represents 
the Cr (100.7 ppm), peak E is due to C4 
(76.8 ppm), peak F is due to CZ, C3, CS 
(72.03 ppm) and peak G is due to Ca (60.5 ppm) 
carbons [ 121. Peaks E-G will have minor contribu- 
tions from sugars free in solution; e.g., glucose. 
The chemical shifts of peaks D-G were measured 
relative to those of peaks I and H. They corres- 
pond closely to those observed in the pure glycogen 
sample. 
We have not assigned the broad peak C but it 
may reflect the y and 6 carbons of histidine, tryp- 
tophan, phenylalanine and tyrosine [7]. Peak B 
(128.7 ppm) corresponds to the single and double- 
bond carbons in fatty acid [9,10] which probably 
derive mainly from phospholipids. The resonance 
at 174 ppm (A) corresponds to the carbonyl car- 
bons of proteins [ 111. The narrow linewidths of the 
triglycerides and other lipids indicate rapid 
molecular motion and have been attributed to 
signals from fats in the triglycerides and the mobile 
parts of membranes [8]. 
3.2. Quantitation of 13C signals 
The intensity of the glycogen signals in livers of 
phosphorylase kinase-deficient rats is clearly much 
greater than that in normal rats, but it is not easy 
to quantitate. Unfortunately there is no single 
signal in these spectra which can be assigned to a 
compound whose concentration has been deter- 
mined by chemical assay. Thus the method of 
relating peak areas to the area of the ATP peak 
and hence to the chemical concentration of ATP, 
which has been widely used in 31P NMR [I] has no 
counterpart in r3C work. The intensities of the 
signals of (CH& and (C=O) carbons are probably 
not proportional to their chemical concentrations, 
since the mobility of fatty acids and other 
substances containing these groups is very variable. 
However, if we assume that the signals from 
(CHz),, are of equal intensity in normal and 
gsd/gsd rat livers and that the same is true of those 
from (C=O), then we can relate these signals to 
those of glycogen in the two groups. 
Table 1 shows the result of such a comparison. 
Integration was carried out using standard soft- 
ware supplied by Bruker; it agreed well with 
manual cutting and weighing of the peaks. The 
ratios of (C=O) : (CH2) are similar in normal and 
gsd/gsd rats, and so it is possible to compare levels 
of glycogen in the gsd/gsd rats with the control 
animals. One must first standardise the glycogen 
peaks observed by NMR by comparing either the 
Table 1 
Metabolite ratios as measured chemically and by ‘%Z NMR in fed and 24 h-starved rat livers of a normal and a 
phosphorylase kinase (gsd/gsd)-deficient strain after normal feeding or 24 h starvation 
NMR Chemical assay 
Cr gly : (CH2)n c2.3.5 cr gly: (C=O) Cz.3.5 (C=O) : (CH& @mol glyco- 
gly : (CH2)n gly : (C=O) gen.g wet 
wt -I) 
Normal (fed)a 0.02 0.10 0.14 0.68 
gsd/gsd (fed) 0.09 0.29 0.58 1.62 
gsd/gsd (fed) : 
normal (fed) 4.5 2.7 4.14 2.5 
gsd/gsd (starved) 0.09 0.39 0.58 2.69 
gsd/gsd (starved) : 
gsd/gsd (fed) 0.9 1.34 1.0 1.55 
a There was no detectable signal from glycogen in livers of starved, normal rats 
0.15 227 + 18 
0.16 663 + 43 
1.0 2.92 
0.15 663 + 36 
1.0 1.0 
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Cr gly or CZ,X,~ gly resonances with the C=O or 
(CH& peaks allowing us to obtain a value for 
glycogen in arbitrary units (table 1, rows 1 and 2). 
From these values a ratio of the glycogen concen- 
trations in normal and gsd/gsd livers may be ob- 
tained (table 1, row 3). While the CI peak can be 
solely attributed to glycogen the Cr gly : (CH& 
ratio and the Cr gly : C=O ratio are less accurate 
than the corresponding c2,3.5 gly:(CH& or 
C2,3,5:C= 0 ratios as the Cr peak is difficult to 
measure in the normal strains and so will tend to 
be underestimated. Comparing ratios derived from 
peak F (C2,3,5 gly) the NMR method gives 2.5 or 
2.7-fold more glycogen in gsd/gsd rats whereas 
a 
chemical assay gives 2.9-fold. 
Fig. 2 shows spectra from a normal liver and a 
gsd/gsd liver in rats that had been starved for 24 h. 
There is complete absence of resonances assigned 
to glycogen in normal strain while levels of 
glycogen remain unchanged in the livers of gsd/gsd 
rats, in good agreement with chemical 
determinations. 
Fig. 3a shows the difference spectrum of the 
spectra of a starved normal rat and a starved 
gsd/gsd rat (fig. 2a,b). The chemical shifts and 
linewidths of the resonances are clearly similar to 
those of pure glycogen in vitro (fig. 3b). Table 1 
(bottom row) compares concentrations obtained 
b I 
I 
Fig. 2. Proton-decoupled 50.24 MHz “C NMR spectra of (a) 24 h-starved rat liver in vivo (2500 scans) (a) normal (b) 
phosphorylase kinase deficient (gsd/gsd). Conditions were as in fig. 1. 
b 
Fig. 3. (a) Difference spectra of fig. 2, spectrum of a 24 h-starved normal rat liver in vivo subtracted from the spectrum 
of a 24 h-starved gsd/gsd rat liver in vivo. (b) Proton decoupled 50.24 MHz 13C NMR spectra of pure glycogen solution 
(10 mg/ml) in Hz0 (10% D20). The spectrum represents 2500 scans; recycle time 1 s; 12 Hz line broadening. 
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for glycogen by NMR (again in arbitrary units) in 
starved gsd/gsd rats with those in fed gsd/gsd rats. 
Once again, there is good agreement with the 
chemical determination. Degradation of purified 
glycogen using amyloglucosidase to give glucose 
was carried out in the NMR machine. The ratio of 
the total visible carbon atoms present as glucose 
and as glycogen was 1.03 indicating that all glucose 
molecules present in the glycogen structure are 
observed by NMR. 
The ability to visualise glycogen by 13C NMR, 
especially in the gsd/gsd strain, indicates that al- 
though the glycogen complex is large there must be 
considerable motion within the structure. Liver 
glycogen is a polydisperse high-M, (up to 109) com- 
pound. Electron microscopy has shown glycogen 
to be composed of single spheres (particles) and 
clusters of spheres (particles) [13]. The latter are 
held together by covalent bonds and are large and 
irregular in shape. Associated with the particulate 
glycogen are a number of enzymes: glycogen syn- 
thetase, phosphorylase, phosphorylase phospha- 
tase and glycogen synthetase phosphatase [14,151 
forming an enzyme-glycogen complex. 
Electron micrographs of livers from gsd/gsd rats 
show that glycogen is evenly distributed through- 
out the cytoplasm, and not associated with orga- 
nelles. The similarity of the NMR and chemical 
assay data on the two strains (table 1) indicates 
that the glycogen must be in a normal environment 
in gsd/gsd livers. This is surprising, since the glyco- 
gen synthesising and degrading enzymes are pre- 
sent in normal amounts [3] so that the ratio of 
enzymes : glycogen complex would be expected to 
be lower than normal. 
4. CONCLUSIONS 
Elevated glycogen levels can be observed in the 
livers of phosphorylase kinase-deficient gsd/gsd 
rats; the degree of elevation is similar to that 
measured by chemical assay. Starvation did not 
significantly reduce the glycogen content of the 
livers with glycogen storage disease whereas it 
reduced the signal below detectability in normal 
rats. Glycogen storage diseases have been 
demonstrated indirectly in skeletal muscle, using 
31P NMR by the absence of a normal acidification 
on exercise [16,17]. These results suggest that 
human glycogen storage diseases, and particularly 
those of the liver, could be diagnosed by r3C NMR 
when whole-body high resolution instruments 
become available. 
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